Early research (Phase 1)Study completedNCT02309801What this trial is testingInteraction Between a Natural Aldehyde Dehydrogenase 2 (ALDH2) Inhibitor and AlcoholWho this might be right forHealthy Parc de Salut Mar 10
Early research (Phase 1)Study completedNCT01488201What this trial is testingA Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe PsoriasisWho this might be right forPsoriasis Kyowa Kirin Co., Ltd. 48
Early research (Phase 1)Study completedNCT00906256What this trial is testingClinical Pharmacology Study of AZD7295 in Healthy SubjectsWho this might be right forHealthy Arrow Therapeutics 16
Early research (Phase 1)Study completedNCT02852239What this trial is testingPharmacokinetics of Dabrafenib in Subjects With Renal ImpairmentWho this might be right forRenal Impairment Novartis Pharmaceuticals 22
Early research (Phase 1)Study completedNCT05203822What this trial is testingTepotinib Drug-Drug Interaction Study With Itraconazole in Healthy ParticipantsWho this might be right forHealthy Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 18
Very early researchStudy completedNCT04223635What this trial is testingStudy of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy ParticipantsWho this might be right forModerate Hepatic Impairment Daiichi Sankyo 16
Early research (Phase 1)Study completedNCT03962049What this trial is testingSafety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic FunctionWho this might be right forHepatic ImpairmentHealthy Participants ObsEva SA 24
Early research (Phase 1)Study completedNCT03961932What this trial is testingSafety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal FunctionWho this might be right forRenal ImpairmentHealthy Participants ObsEva SA 33
Early research (Phase 1)Study completedNCT02359292What this trial is testingClinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy VolunteersWho this might be right forAsthma Chiesi Farmaceutici S.p.A. 50
Early research (Phase 1)Study completedNCT04364464What this trial is testingStudy on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and WeightWho this might be right forClinical Pharmacology Bayer 40
Early research (Phase 1)WithdrawnNCT03390647What this trial is testingEvaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Male ParticipantsWho this might be right forHealthy Participants EA Pharma Co., Ltd.
Early research (Phase 1)Study completedNCT02048787What this trial is testingPharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.Who this might be right forRenal Impairment Novartis Pharmaceuticals 19
Early research (Phase 1)Study completedNCT03929861What this trial is testingBioequivalence Trial to Prove Equal Blood Concentrations of Two Different Fluconazole FormulationsWho this might be right forPharmacology, Clinical Bayer 26
Testing effectiveness (Phase 2)Study completedNCT04087707What this trial is testingSafety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy SubjectsWho this might be right forHealthy Volunteer Taisho Pharmaceutical Co., Ltd. 23
Early research (Phase 1)Study completedNCT01611415What this trial is testingDrug to Drug Interaction Study With Ipragliflozin and FurosemideWho this might be right forHealthy SubjectsPharmacokinetics of Ipragliflozin Astellas Pharma Europe B.V. 24
Not applicableStudy completedNCT06710600What this trial is testingPhototoxicity of Frequently Prescribed MedicinesWho this might be right forPhototoxicity Medical University of Vienna 12
Early research (Phase 1)Study completedNCT01473108What this trial is testingStudy to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862Who this might be right forClinical Pharmacology Bayer 67
Early research (Phase 1)Study completedNCT02049528What this trial is testingStudy to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effect StudyWho this might be right forClinical Pharmacology, Healthy Male Volunteer Study Celgene 18
Early research (Phase 1)Looking for participantsNCT07374224What this trial is testingA Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib TabletWho this might be right forClinical Pharmacology Guangzhou Lupeng Pharmaceutical Company LTD. 28
Early research (Phase 1)Study completedNCT03942666What this trial is testingPK Linearity and Steady State PK of CHF 6532 in Healthy SubjectsWho this might be right forAsthma Chiesi Farmaceutici S.p.A. 30